Testing new cancer treatments on cells from ovarian cancer fluid
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This laboratory study uses ovarian cancer fluid collected during surgery to test possible new treatments on cancer and immune cells. It may help researchers find better treatment options in ovarian cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older having surgery to remove ovarian cancer tissue
- Doctors suspect ovarian (or related) cancer and surgery is planned for tumor removal
- Your cancer type must be epithelial ovarian cancer (including fallopian tube or primary peritoneal cancer)
- If you could become pregnant, your pregnancy test must be negative within 2 weeks before the study
- You must be able to read, understand, and sign the consent form yourself
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
This study is testing new blood tests that might help detect ovarian cancer earlier by looking for specific markers. It involves people with suspected ovarian cancer and healthy volunteers, and aims to improve how we diagnose the disease.
This Phase 1 study tests whether giving your own immune cells—engineered to target the FSH receptor—can control recurrent ovarian-related cancers. It’s mainly looking at safety and early signs of activity for patients whose cancer has not responded well to standard platinum chemotherapy.
This study is testing a blood test to see if it can catch ovarian cancer early. You may be eligible if you have been recently diagnosed with ovarian cancer and haven't started treatment yet.
This trial tests a personalized treatment using your own immune cells (called TILs) to fight ovarian cancer that has returned. After collecting and growing these cells, you receive chemotherapy and other drugs to help them work better.
This trial uses a small piece of your cancer tissue (taken during surgery) to grow 'mini-tumors' in the lab. These help doctors find which treatments might work best for you. It is for people with advanced serous ovarian cancer.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.